Phase I trial of NAS 911IPF in patients with idiopathic pulmonary fibrosis

Trial Profile

Phase I trial of NAS 911IPF in patients with idiopathic pulmonary fibrosis

Planning
Phase of Trial: Phase I

Latest Information Update: 24 Sep 2014

At a glance

  • Drugs NAS-911 (Primary)
  • Indications Idiopathic pulmonary fibrosis
  • Focus Adverse reactions
  • Sponsors New Amsterdam Sciences
  • Most Recent Events

    • 24 Sep 2014 New trial record
    • 21 Aug 2014 New Amsterdam Sciences is advancing NAS 911IPF into phase I trials and preparing to submit an IND, according to a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top